Our results demonstrated that the overexpression of TGFBR2 or treatment with the demethylating agent 5-Aza-2′-deoxycytidine significantly induced cell cycle arrest in ESCC cell lines. The gene discussed is TGFBR2; the disease is esophageal squamous cell carcinoma.